Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,836
Closed -$51K 2085
2016
Q4
$51K Hold
1,836
﹤0.01% 1360
2016
Q3
$50K Hold
1,836
﹤0.01% 1354
2016
Q2
$40K Sell
1,836
-2,745
-60% -$59.8K ﹤0.01% 1382
2016
Q1
$102K Hold
4,581
﹤0.01% 1206
2015
Q4
$127K Hold
4,581
﹤0.01% 1188
2015
Q3
$118K Hold
4,581
﹤0.01% 1183
2015
Q2
$114K Sell
4,581
-1,424
-24% -$35.4K ﹤0.01% 1165
2015
Q1
$141K Hold
6,005
﹤0.01% 1121
2014
Q4
$117K Sell
6,005
-7,480
-55% -$146K ﹤0.01% 1126
2014
Q3
$307K Buy
13,485
+2,224
+20% +$50.6K 0.01% 504
2014
Q2
$275K Sell
11,261
-1,647
-13% -$40.2K 0.01% 531
2014
Q1
$197K Hold
12,908
0.01% 586
2013
Q4
$220K Sell
12,908
-4,571
-26% -$77.9K 0.01% 555
2013
Q3
$278K Sell
17,479
-16,862
-49% -$268K 0.01% 526
2013
Q2
$683K Buy
+34,341
New +$683K 0.02% 462

Other funds holding QGENF

QS Investors's QGENF Position: Q1 2017 in Review

QS Investors sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 1,836 shares — an estimated $51K sold.

QS Investors first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $683K in Q2 2013. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • QS Investors reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • QS Investors sold 1,836 QIAGEN NV shares in Q1 2017, an estimated $51K.
  • QS Investors first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • QS Investors's QIAGEN NV position peaked at $683K in Q2 2013.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on QS Investors's 13F filing for Q1 2017, filed 15 May 2017.